Jefferies Group LLC Nektar Therapeutics Transaction History

Jefferies Group LLC

$10.2 Billion
Q3 2022

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$3.17 - $6.17 $315,548 - $614,174	-99,542 Reduced 59.2%	68,610 $12,000
Q1 2022 Sep 21, 2023	BUY	$4.16 - $13.72 $97,926 - $322,968	23,540 Added 32.82%	95,266 $513,000
Q1 2022 May 16, 2022	BUY	$4.16 - $13.72 $401,132 - $1.32 Million	96,426 Added 134.44%	168,152 $494,000
Q4 2021 Sep 21, 2023	BUY	$10.83 - $18.41 $560,192 - $952,275	51,726 Added 258.63%	71,726 $969,000
Q4 2021 Feb 14, 2022	BUY	$10.83 - $18.41 $776,792 - $1.32 Million	71,726 New	71,726 $969,000
Q3 2021 Nov 15, 2021	SELL	$13.07 - $18.84 $261,400 - $376,800	-20,000 Closed	0 $0
Q2 2021 Sep 21, 2023	BUY	$16.52 - $20.4 $330,400 - $408,000	20,000 New	20,000 $343,000
Q2 2021 Aug 16, 2021	BUY	$16.52 - $20.4 $330,400 - $408,000	20,000 New	20,000 $343,000
Q1 2020 May 15, 2020	SELL	$14.47 - $27.96 $750,052 - $1.45 Million	-51,835 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$15.87 - $23.12 $822,621 - $1.2 Million	51,835 New	51,835 $1.12 Million
Q3 2019 Nov 13, 2019	SELL	$16.91 - $36.27 $918,534 - $1.97 Million	-54,319 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$31.0 - $36.3 $1.42 Million - $1.66 Million	45,719 Added 531.62%	54,319 $1.93 Million
Q1 2019 May 15, 2019	SELL	$31.58 - $46.35 $1.25 Million - $1.83 Million	-39,492 Reduced 82.12%	8,600 $289,000
Q3 2018 Nov 14, 2018	BUY	$46.46 - $68.49 $1.61 Million - $2.38 Million	34,707 Added 259.3%	48,092 $2.93 Million
Q2 2018 Aug 14, 2018	BUY	$46.25 - $104.45 $619,056 - $1.4 Million	13,385 New	13,385 $654,000
Q1 2018 May 15, 2018	SELL	$57.4 - $108.44 $1.15 Million - $2.17 Million	-20,000 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$23.02 - $60.5 $460,400 - $1.21 Million	20,000	20,000 $1.19 Million

Others Institutions Holding NKTR

# of Institutions

146

Shares Held

139M

Call Options Held

32.6K

Put Options Held

14.1K

Deep Track Capital, LP Greenwich, CT

15.9M
Shares

$17 Million
0.76% of portfolio
Black Rock Inc. New York, NY

15.2M
Shares

$16.2 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

13.1M
Shares

$14 Million
0.0% of portfolio
Eventide Asset Management, LLC Boston, MA

9.4M
Shares

$10.1 Million
0.22% of portfolio
Samlyn Capital, LLC New York, NY

9.2M
Shares

$9.84 Million
0.19% of portfolio

View Full List

About NEKTAR THERAPEUTICS

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $201M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

More about NKTR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.

Account